Dr. Schmelzer’s Turning Point: How a Severe Chest Pain Case Inspired PMcardio Adoption
The case of a 76-year-old patient with severe chest pain prompted Dr. Schmelzer to delve into the nuances of Occlusive Myocardial Infarction (OMI) versus the conventional STEMI/NSTEMI classification. His research led him to discover the PMcardio OMI AI model.
As a residency-trained emergency physician from the University of Michigan with 17 years of experience, Dr. Schmelzer, has witnessed firsthand the critical importance of accurate and timely cardiac diagnosis. His center manages an annual volume of 89,000 visits, and precision in cardiac care is paramount.
”One case that profoundly impacted my approach involved a 76-year-old woman who presented to a rural emergency department with severe chest pain and multiple risk factors for coronary artery disease. Initial assessments, including ECGs and high-sensitivity troponin tests, were inconclusive, yet her chest pain persisted. When transferred to our referral center, her condition was still ambiguous based on traditional methods, leading to delayed cardiac catheterization.”
This case prompted Dr. Schmelzer to delve into the nuances of Occlusive Myocardial Infarction (OMI) versus the conventional STEMI/NSTEMI classification. His research led him to the discovery of PMcardio, an AI-powered ECG interpretation platform.
”Feeding the patient’s EKGs into the PMcardio’s model consistently indicated an OMI, underscoring the need for immediate intervention.’’
Armed with PMcardio, Dr. Schmelzer now confidently shares anonymized digitized ECGs with cardiology colleagues, advocating for the adoption of advanced diagnostic approaches.
Share this article
About PMcardio
PMcardio is a CE-marked Class IIb AI medical device that interprets any 12-lead ECG — from a photo or a digital file — in seconds. It detects 50+ ECG findings, including occlusion myocardial infarction (OMI) — the acute coronary occlusions that conventional STEMI criteria miss in over half of cases. Its Queen of Hearts™ OMI model holds FDA Breakthrough Device Designation, and PMcardio is already used by 100,000+ clinicians who have analyzed more than 2.5 million ECGs.
About Powerful Medical
Powerful Medical is a medical-technology company using artificial intelligence to transform how cardiovascular disease — the world’s leading cause of death — is diagnosed. Founded in 2017, it built PMcardio, the world’s first AI medical device to detect acute coronary occlusion (OMI) from an ECG. Its research is published in the European Heart Journal – Digital Health and validated across 25+ clinical studies, and its Queen of Hearts™ model earned FDA Breakthrough Device Designation. To date, PMcardio has supported the detection of 120,000+ heart attacks across 150+ hospital deployments worldwide.
